The FDA has cleared PhAST Corp’s PhAST BC GN Panel, an automated phenotypic AST system that delivers antimicrobial susceptibility results from positive blood cultures in as little as 99 minutes.
Siemens Healthineers has introduced the CN-3000 and CN-6000 hemostasis analyzers in the US, offering integrated testing methodologies and up to 13 hours of walkaway time for mid- and high-volume clinical laboratories.
Source BioScience has signed a three-year agreement with Sectra to use its Image Exchange Portal, aiming to digitally route up to 60,000 NHS pathology cases to external specialist pathologists in the first year.
The Association for Diagnostics & Laboratory Medicine recommends that AI tools in clinical labs remain under existing CLIA oversight, citing the need for established validation and monitoring standards in response to a federal RFI.
The University of Reading has developed the TRIPLEcheck assay to personalize antiplatelet therapy by assessing platelet reactivity, with a 400-patient clinical trial underway.
